Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing

被引:0
作者
Peter Ferenci
机构
[1] University of Vienna,Departments of Internal Medicine IV, Gastroenterology and Hepatology
来源
Human Genetics | 2006年 / 120卷
关键词
Common Mutation; Wilson Disease; Copper Metabolism; Serum Ceruloplasmin; ATP7B Gene;
D O I
暂无
中图分类号
学科分类号
摘要
Wilson disease is an autosomal recessive inherited disorder of copper metabolism. The Wilson disease gene codes for a copper transporting P-type ATPase (ATP7B). Molecular genetic analysis reveals at least 300 distinct mutations. While most reported mutations occur in single families, a few are more common. The most common mutation in patients from Central, Eastern, and Northern Europe is the point mutation H1069Q (exon 14). About 50–80% of Wilson disease (WD) patients from these countries carry at least one allele with this mutation with an allele frequency ranging between 30 and 70%. Other common mutations in Central and Eastern Europe are located on exon 8 (2299insC, G710S), exon 15 (3400delC) and exon 13 (R969Q). The allele frequency of these mutations is lower than 10%. In Mediterranean countries there is a wide range of mutations, the frequency of each of them varies considerably from country to country. In Sardinia, a unique deletion in the 5′ UTR (−441/−427 del) is very frequent. In mainland Spain the missense mutation M645R in exon 6 is particularly common. Data from non-European countries are scarce. Most data from Asia are from Far Eastern areas (China, South Korea and Japan) where the R778L missense mutation in exon 8 is found with an allele frequency of 14–49%. In summary, given the constant improvement of analytic tools genetic testing will become an integral part for the diagnosis of WD. Knowledge of the differences in the worldwide distribution of particular mutations will help to design shortcuts for genetic diagnosis of WD.
引用
收藏
页码:151 / 159
页数:8
相关论文
共 264 条
[1]  
Al Jumah M(2004)clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations Eur J Neurol 11 121-124
[2]  
Majumdar R(2001)High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis J Hepatol 35 575-581
[3]  
Al Rajeh S(2004)Intracellular trafficking of the human Wilson protein: the role of the six N-terminal metal-binding sites Biochem J 380 805-813
[4]  
Awada A(1999)A study of Wilson disease mutations in Britain Hum Mutat 14 304-311
[5]  
Al Zaben A(2000)Copper-induced conformational changes in the N-terminal domain of the Wilson disease copper-transporting ATPase Biochemistry 39 1890-1896
[6]  
Al Traif I(2004)Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients Hum Mutat 398 1-8
[7]  
Caca K(2005a)Wilson’s disease (clinical genomics) Clin Gastroenterol Hepatol 3 726-733
[8]  
Ferenci P(2003)Diagnosis and phenotypic classification of Wilson disease. Final report of the proceedings of the working party at the 8th international meeting on Wilson disease and Menkes disease, Leipzig/Germany, 2001 Liver Int 23 139-142
[9]  
Kuhn HJ(2005a)Diagnostic value of quantitative hepatic copper determination in patients with Wilson disease Clin Gastroenterol Hepatol 3 811-818
[10]  
Polli C(2005b)Phenotype–genotype correlations in Wilson Disease (WD)—results of a multinational study Hepatology 42 258A-1324